Scarica l'app Stockscreener
5.9691
0.15%
0.0091
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.96
Aprire:
$5.93
Volume 24 ore:
252.63K
Relative Volume:
0.13
Capitalizzazione di mercato:
$523.98M
Reddito:
$30.91M
Utile/perdita netta:
$-209.47M
Rapporto P/E:
-1.7937
EPS:
-3.3279
Flusso di cassa netto:
$-147.13M
1 W Prestazione:
+10.53%
1M Prestazione:
+8.92%
6M Prestazione:
-24.73%
1 anno Prestazione:
-8.60%
Intervallo 1D:
$5.90
$6.00
Intervallo di 1 settimana:
$5.35
$6.08
Portata 52W:
$4.01
$11.24
Verastem Inc Stock (VSTM) Company Profile
Nome
Verastem Inc
Settore
Industria
Telefono
(781) 292-4200
Indirizzo
117 KENDRICK STREET, NEEDHAM, MA
Compare VSTM vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VSTM
Verastem Inc
|
5.965 | 523.54M | 30.91M | -209.47M | -147.13M | -3.3279 |
VRTX
Vertex Pharmaceuticals Inc
|
425.06 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.63 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
809.16 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
302.47 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.76 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Verastem Inc Stock (VSTM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Ripresa | BTIG Research | Buy |
| 2026-02-04 | Iniziato | H.C. Wainwright | Buy |
| 2025-10-16 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-04-10 | Iniziato | Jefferies | Buy |
| 2025-03-24 | Reiterato | H.C. Wainwright | Buy |
| 2024-12-31 | Reiterato | BTIG Research | Buy |
| 2024-09-30 | Iniziato | Guggenheim | Buy |
| 2023-11-21 | Ripresa | BTIG Research | Buy |
| 2023-09-27 | Iniziato | B. Riley Securities | Buy |
| 2023-06-15 | Aggiornamento | Mizuho | Neutral → Buy |
| 2022-09-07 | Ripresa | Alliance Global Partners | Buy |
| 2022-04-29 | Ripresa | Cantor Fitzgerald | Overweight |
| 2022-04-14 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-09 | Iniziato | Truist | Buy |
| 2021-07-01 | Iniziato | Alliance Global Partners | Buy |
| 2021-05-24 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-06-20 | Downgrade | BTIG Research | Buy → Neutral |
| 2019-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2018-07-13 | Iniziato | BTIG Research | Buy |
| 2018-05-02 | Iniziato | Seaport Global Securities | Buy |
| 2018-03-08 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-09-07 | Reiterato | H.C. Wainwright | Buy |
| 2017-04-13 | Iniziato | Oppenheimer | Outperform |
| 2017-03-24 | Reiterato | H.C. Wainwright | Buy |
| 2015-09-29 | Downgrade | Cantor Fitzgerald | Buy → Hold |
| 2015-09-29 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-09-29 | Downgrade | Jefferies | Buy → Hold |
| 2015-09-29 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2015-09-28 | Downgrade | Mizuho | Buy → Neutral |
| 2015-09-28 | Downgrade | ROTH Capital | Buy → Neutral |
| 2015-09-09 | Iniziato | Raymond James | Strong Buy |
| 2015-05-12 | Reiterato | UBS | Buy |
| 2015-04-08 | Iniziato | H.C. Wainwright | Buy |
| 2015-01-23 | Reiterato | ROTH Capital | Buy |
| 2014-07-08 | Ripresa | Oppenheimer | Perform |
| 2014-02-11 | Iniziato | Mizuho | Buy |
Mostra tutto
Verastem Inc Borsa (VSTM) Ultime notizie
MSN Money - MSN
Earnings Preview: Verastem to Report Financial Results on May 07 - Moomoo
Verastem Oncology Launches HCP and Patient Reimagine Campaign to Increase Awareness of AVMAPKI® FAKZYNJA® CO-PACK for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer - BioSpace
Verastem (VSTM) Launches Campaign for Recurrent Low-Grade Serous Ovarian Cancer - GuruFocus
KRAS-mutated LGSOC campaign debuts as Verastem, Inc. targets patient support - Traders Union
Verastem (VSTM) Projected to Post Earnings on Thursday - MarketBeat
Mizuho Securities Adjusts Verastem Price Target to $16 From $18, Maintains Outperform Rating - marketscreener.com
CapEx per share of Verastem, Inc. – MUN:2VSA - TradingView
Verastem to Present at the 8th Annual JMP Securities Healthcare Conference - AOL.com
Liquidity Mapping Around (VSTM) Price Events - Stock Traders Daily
Verastem Oncology announces management changes - MSN
VSTM Price Today: Verastem, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Verastem, Inc. (NASDAQ:VSTM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
VSTM Reiterated by BTIG -- Price Target Maintained at $19.00 - GuruFocus
Torray Investment Partners LLC Purchases Shares of 216,387 Verastem, Inc. $VSTM - MarketBeat
Verastem, Inc. sets first quarter earnings call for May 7 at 4:30pm ET - Traders Union
Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026 - ChartMill
VSTM Technical Analysis | Trend, Signals & Chart Patterns | VERASTEM INC (NASDAQ:VSTM) - ChartMill
Verastem Inc stock (US92335V1008): Is its oncology pipeline strong enough to unlock biotech upside? - AD HOC NEWS
BTIG Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $19 - Moomoo
Verastem's (VSTM) Buy Rating Reaffirmed at BTIG Research - MarketBeat
Verastem (NASDAQ:VSTM) Trading Down 4.1%Here's Why - MarketBeat
Verastem (VSTM) Stock Growth Drivers (Momentum Fading) 2026-04-20Retail Trader Ideas - Cổng thông tin điện tử tỉnh Lào Cai
Vectoring In On Verastem (NASDAQ:VSTM) - Seeking Alpha
Verastem Inc stock (US92335V1008): Is its cancer therapy pipeline strong enough to unlock new upside - AD HOC NEWS
Verastem (VSTM) Stock: Cheap or Expensive (+3.79%) 2026-04-18Social Trade Signals - Cổng thông tin điện tử tỉnh Lào Cai
Verastem (VSTM) Stock: Is It a Strong Buy? (Extends Gains) 2026-04-18Trend Analysis - Cổng thông tin điện tử tỉnh Lào Cai
Verastem, Inc. (VSTM) Stock Analysis: 158% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
VSTM Stock Chart | VERASTEM INC (NASDAQ:VSTM) - ChartMill
Why (VSTM) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Mizuho Securities Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $16 - Moomoo
Q4 2025 Verastem Inc Earnings Call Transcript - GuruFocus
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results - Eastern Progress
PI3K Inhibitor Drug Class Market (2026-2033) | PI3Kα, PI3Kβ, - openPR.com
Chipmakers Recap: How is Verastem Inc managing supply chain issues2026 Support & Resistance & Long Hold Capital Preservation Tips - baoquankhu1.vn
Verastem (NASDAQ:VSTM) Trading Up 7.6%What's Next? - MarketBeat
Aug Wrap: What analysts say about Verastem Inc stock2026 Bull vs Bear & Weekly High Return Forecasts - baoquankhu1.vn
H.C. Wainwright reiterates Verastem stock rating on durable trial data By Investing.com - Investing.com Canada
Is momentum building in Verastem (VSTM) Stock | Price at $5.63, Up 6.03%Trade Ideas - UBND thành phố Hải Phòng
Sentiment Recap: What analysts say about Verastem Inc stockTrade Entry Report & AI Optimized Trade Strategies - baoquankhu1.vn
Verastem Oncology’s combo shows two-year durability in ovarian cancer - MSN
Fed Meeting: What is the Moat Score of Verastem IncQuarterly Earnings Report & Consistent Income Trade Recommendations - baoquankhu1.vn
Today's Analyst Rating Data for VSTM: Maintained Buy Rating | VS - GuruFocus
Today's Analyst Rating for VSTM: Maintains Buy Rating at $18.00 | VSTM Stock News - GuruFocus
Today's Analyst Rating for VSTM: Maintains Buy Rating at $18.00 - GuruFocus
Verastem stock maintains Buy rating at BTIG on durable trial data - Investing.com Canada
Verastem (NASDAQ:VSTM) Earns "Buy" Rating from BTIG Research - MarketBeat
Verastem (VSTM) Presents Positive Two-Year Data for Ovarian Canc - GuruFocus
Verastem’s cancer drug combo shows durability in 2-year data By Investing.com - Investing.com India
Verastem’s cancer drug combo shows durability in 2-year data - Investing.com
Verastem Oncology announces two-year median follow-up data on Avmapki® Fakzynja® combination therapy - marketscreener.com
Verastem Inc Azioni (VSTM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.78%
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):